Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Eli Lilly: Three Products, One Molecule, Total Dominance Lilly's GLP-1 franchise is built on tirzepatide, a dual GLP-1/GIP receptor agonist, sold as Mounjaro for type 2 diabetes and Zepbound for obesity
I'm on my third month and have already lost 15 pounds. Complete your intake today
Sohere we go again
One membership
GLP-1 receptor agonist medications mimic the hormones naturally found in our gut to delay gastric emptying (slow down the rate at which food moves through our digestive tract, which keeps us feeling fuller for more extended periods)
Before starting retatrutide (within a trial setting), your clinician should: Conduct a thorough medical history review , including assessment of conditions that may be trial exclusion criteria or require particular caution for example, a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2)
